Premium
Consideration of free coagulant hemodialysis within our facility
Author(s) -
Ishida Y.,
Kasahara M.,
Sakaji I.,
Yoshikawa M.,
Nitta T.,
Matsushima Y.,
Iwatani Y,
Yoshimoto A.,
Suzuki T.
Publication year - 2005
Publication title -
hemodialysis international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.658
H-Index - 47
eISSN - 1542-4758
pISSN - 1492-7535
DOI - 10.1111/j.1492-7535.2005.1121p.x
Subject(s) - hemodialysis , medicine , blockade , dialysis , membrane , dialysis tubing , surgery , anesthesia , chemistry , biochemistry , receptor
Purpose: Performed free coagulant hemodialysis to patients having hemorrhage with the hope to avoid aggravation of bleeding caused by anticoagulant agent from dialysis. Method: Examined 19 cases of patients with bleeding tendency, whether it is possible to perform free coagulant hemodialysis by using PAES membrane, EVAL membrane, PS membrane, Cellulose triacetate membrane and Vitamin‐E modified‐dialysis membrane. Result: With PAES membrane, the result showed a non‐ blockade rate of 91% after four hours and 100% after two hours. Therefore, blockade was prevented with a fairly high rate. In cases of blockade, most of them were possibly avoidable with a little contrivance as the reason were lack of establish blood flow rate, faulty position of a needle, etc. Conclusions: By using PAES membrane, it was possible to perform free coagulant hemodialysis. In order to completely have no blockade of blood lines in the future, we must strive further on.